lanabecestat: Clinical Trials

1 trial of lanabecestat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow lanabecestat: new trials by email Literature Review of lanabecestat trials Research Report on lanabecestat

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
Lanabecestat, Placebo - Alzheimer´s Disease
Phase 2 / Phase 3TerminatedAstraZeneca22182014-09-302019-12-03

Conditions studied

Alzheimer Disease (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Tauopathies (1)

Sponsors

AstraZeneca (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 27767991, PMID 31764959, PMID 33049114, PMID 40603145

NIH funding

2014 (1)